Search

everythinglearnresearchcommunity

for

Search:↓

Docetaxel is effective against various cancers but mainly causes neutropenia.

Ritlecitinib effectively treats severe Alopecia Areata by reducing harmful immune activity in the skin.

Early diagnosis and multidisciplinary care are crucial for managing CNOT3 syndrome.

MK-5108 is safe and shows potential against tumors, especially alone.

Cystatin M/E strongly inhibits cathepsin V and cathepsin L, important for skin formation.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

Smart nano-PROTACs improve cancer treatment by targeting proteins more precisely and reducing side effects.

Brepocitinib effectively reduces inflammation and improves symptoms in cicatricial alopecia with good safety.

Toe Tourniquet Syndrome is often misdiagnosed.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

A new method helps manage skin side effects from hormonal cancer therapy, improving patient care.

The method effectively induces skin cancer in mice for studying tumor development.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

The document concludes that central centrifugal cicatricial alopecia (CCCA) should be considered in African American men with vertex hair loss and scalp symptoms, and that prompt diagnosis and treatment can slow disease progression.

Inhibiting connective tissue sheath contraction may improve hair growth in male pattern baldness.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

Topical tofacitinib shows promise as a future treatment for alopecia areata.

Tofacitinib significantly improved symptoms in a patient with overlapping autoimmune disorders.

Baricitinib helped improve hair, eyebrow, and eyelash growth in alopecia areata patients.

Hair-tourniquet syndrome can cause serious toe injuries in infants but can be treated if found early.

A boy with chromosome 13q deletion syndrome developed eye cancer, a woman with breast cancer lost vision due to a rare side-effect of her treatment, a man's vision worsened after using a hair loss drug, and two rare disorders were discussed. Optical Coherence Tomography is useful for diagnosing and monitoring these conditions.

Surgical excision is the best treatment for SCC, but intralesional cidofovir might be a good alternative.

Tofacitinib helped a woman regrow hair with no major side effects.

A new compound shows promise as a topical treatment for hair loss.

Tofacitinib effectively treats severe alopecia areata, improving hair regrowth and patient satisfaction.

The combination of high-dose toremifene and capecitabine was effective for advanced recurrent breast cancer.

CD8+ T cells expand significantly in alopecia areata, suggesting new treatment targets.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

A pathway helps maintain long telomeres in both stem and cancer cells.